Versant Venture Management, LLC Long-Term Concentrated

CIK: 0001560009 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 12, 2020

Total Value ($000): $546,369 (100.0% shares, 0.0% debt)

Holdings (11)

CRSP CRISPR Therapeutics AG 55.6%

Value ($000) $303,752 Shares 3,631,656 Est. Cost $40.26 Unrealized +120.3%

— Adverum Biotechnologies, Inc. 13.2%

Value ($000) $72,140 Shares 7,003,892 Est. Cost $9770.00 Unrealized —

— Aprea Therapeutics, Inc. 8.2%

Value ($000) $44,613 Shares 1,854,229 Est. Cost $38780.00 Unrealized —

— Flexion Therapeutics, Inc. 7.3%

Value ($000) $40,001 Shares 3,842,578 Est. Cost $10.41 Unrealized —

CRNX Crinetics Pharmaceuticals, Inc. 5.8%

Value ($000) $31,820 Shares 2,030,616 Est. Cost $17.05 Unrealized -10.3%

— Akero Therapeutics, Inc. 4.4%

Value ($000) $23,946 Shares 777,727 Est. Cost $21200.00 Unrealized —

OCUL Ocular Therapeutix, Inc. 3.1%

Value ($000) $16,859 Shares 2,215,384 Est. Cost $20.09 Unrealized -58.7%

— Gritstone Oncology, Inc. 1.5%

Value ($000) $8,223 Shares 3,102,929 Est. Cost $11140.00 Unrealized —

— CymaBay Therapeutics, Inc. 0.7%

Value ($000) $3,937 Shares 543,753 Est. Cost $9871.60 Unrealized —

— Clovis Oncology, Inc. 0.1%

Value ($000) $594 Shares 101,855 Est. Cost $56000.00 Unrealized —

— Second Sight Medical Products, Inc. 0.1%

Value ($000) $484 Shares 561,612 Est. Cost $1210.00 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CRSP	CRISPR Therapeutics AG	3,631,656	$303,752	55.6%	$40.26	+120.3%	Common Stock	H17182108
—	Adverum Biotechnologies, Inc.	7,003,892	$72,140	13.2%	$9770.00	—	Common Stock	00773U108
—	Aprea Therapeutics, Inc.	1,854,229	$44,613	8.2%	$38780.00	—	Common Stock	03836J102
—	Flexion Therapeutics, Inc.	3,842,578	$40,001	7.3%	$10.41	—	Common Stock	33938J106
CRNX	Crinetics Pharmaceuticals, Inc.	2,030,616	$31,820	5.8%	$17.05	-10.3%	Common Stock	22663K107
—	Akero Therapeutics, Inc.	777,727	$23,946	4.4%	$21200.00	—	Common Stock	00973Y108
OCUL	Ocular Therapeutix, Inc.	2,215,384	$16,859	3.1%	$20.09	-58.7%	Common Stock	67576A100
—	Gritstone Oncology, Inc.	3,102,929	$8,223	1.5%	$11140.00	—	Common Stock	39868T105
—	CymaBay Therapeutics, Inc.	543,753	$3,937	0.7%	$9871.60	—	Common Stock	23257D103
—	Clovis Oncology, Inc.	101,855	$594	0.1%	$56000.00	—	Common Stock	189464100
—	Second Sight Medical Products, Inc.	561,612	$484	0.1%	$1210.00	—	Common Stock	81362J100